Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile
F. Kommoss, Anthony N. Karnezis, Friedrich Kommoss, et al.
British Journal of Cancer (2018) Vol. 119, Iss. 4, pp. 480-486
Open Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
Nicole Concin, Xavier Matías‐Guiu, Ignace Vergote, et al.
International Journal of Gynecological Cancer (2020) Vol. 31, Iss. 1, pp. 12-39
Open Access | Times Cited: 1380
Endometrial cancer
Emma J. Crosbie, Sarah Kitson, Jessica N. McAlpine, et al.
The Lancet (2022) Vol. 399, Iss. 10333, pp. 1412-1428
Open Access | Times Cited: 759
PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer
Anne Sophie V M van den Heerik, Nanda Horeweg, Remi A. Nout, et al.
International Journal of Gynecological Cancer (2020) Vol. 30, Iss. 12, pp. 2002-2007
Open Access | Times Cited: 201
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
Nicole Concin, Xavier Matías‐Guiu, Ignace Vergote, et al.
Radiotherapy and Oncology (2021) Vol. 154, pp. 327-353
Open Access | Times Cited: 189
ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma
Nicole Concin, Carien L. Creutzberg, Ignace Vergote, et al.
Virchows Archiv (2021) Vol. 478, Iss. 2, pp. 153-190
Closed Access | Times Cited: 150
Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy
Anne Sophie V M van den Heerik, Nanda Horeweg, Stephanie M. de Boer, et al.
International Journal of Gynecological Cancer (2020) Vol. 31, Iss. 4, pp. 594-604
Open Access | Times Cited: 141
The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment Decisions
Matthias Alexa, Annette Hasenburg, Marco Johannes Battista
Cancers (2021) Vol. 13, Iss. 6, pp. 1478-1478
Open Access | Times Cited: 138
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
Lisa Vermij, Jan J. Jobsen, Alicia León‐Castillo, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 7, pp. 1360-1368
Open Access | Times Cited: 87
Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratification
Soyoun Rachel Kim, Basile Tessier Cloutier, Samuel Leung, et al.
Gynecologic Oncology (2020) Vol. 158, Iss. 1, pp. 3-11
Closed Access | Times Cited: 98
Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification
Jenneke C. Kasius, Johanna M.A. Pijnenborg, Kristina Lindemann, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5848-5848
Open Access | Times Cited: 65
Genomic landscape of endometrial carcinomas of no specific molecular profile
Amir Momeni Boroujeni, Bastien Nguyen, Chad Vanderbilt, et al.
Modern Pathology (2022) Vol. 35, Iss. 9, pp. 1269-1278
Open Access | Times Cited: 59
Biomolecular and Genetic Prognostic Factors That Can Facilitate Fertility-Sparing Treatment (FST) Decision Making in Early Stage Endometrial Cancer (ES-EC): A Systematic Review
Panayiotis Tanos, Savvas Dimitriou, Giuseppe Gullo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2653-2653
Open Access | Times Cited: 45
Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients – An international pooled analysis of three ESGO accredited centres
Richard Schwameis, Francesco Fanfani, Christoph Ebner, et al.
European Journal of Cancer (2023) Vol. 193, pp. 113317-113317
Open Access | Times Cited: 42
Endometrial Cancer: Transitioning from Histology to Genomics
Cristina Mitric, Marcus Q. Bernardini
Current Oncology (2022) Vol. 29, Iss. 2, pp. 741-757
Open Access | Times Cited: 40
2023 changes to FIGO endometrial cancer staging: Counterpoint
Mario M. Leitao
Gynecologic Oncology (2024) Vol. 184, pp. 146-149
Closed Access | Times Cited: 14
Potential of molecular classification to guide fertility-sparing management among young patients with endometrial cancer
Núria Agustí, Alexa Kanbergs, Roni Nitecki
Gynecologic Oncology (2024) Vol. 185, pp. 121-127
Open Access | Times Cited: 10
Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D
S. Timmerman, Anne‐Sophie Van Rompuy, Toon Van Gorp, et al.
Gynecologic Oncology (2020) Vol. 157, Iss. 1, pp. 245-251
Open Access | Times Cited: 51
The frequency of POLE-mutation in endometrial carcinoma and prognostic implications: a systemic review and meta-analysis
Alaa Salah Jumaah, Mais Muhammed Salim, Hawraa Sahib Al‐Haddad, et al.
Journal of Pathology and Translational Medicine (2020) Vol. 54, Iss. 6, pp. 471-479
Open Access | Times Cited: 51
Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas
Amy Jamieson, Lisa Vermij, Claire J.H. Kramer, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 23, pp. 4949-4957
Open Access | Times Cited: 20
Molecular profile is a strong predictor of the pattern of recurrence in patients with endometrial cancer
Ana Luzarraga Aznar, Vicente Bebia, Carlos López-Gil, et al.
International Journal of Gynecological Cancer (2024) Vol. 34, Iss. 5, pp. 659-666
Closed Access | Times Cited: 8
Impact of molecular profile on prognosis and relapse pattern in low and intermediate risk endometrial cancer
Kristina Lindemann, Wanja Kildal, Andreas Kleppe, et al.
European Journal of Cancer (2024) Vol. 200, pp. 113584-113584
Closed Access | Times Cited: 7
Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study
Casper Reijnen, Evangelia Gogou, Nicole C.M. Visser, et al.
PLoS Medicine (2020) Vol. 17, Iss. 5, pp. e1003111-e1003111
Open Access | Times Cited: 42
Proteomic Analysis of Low-Grade, Early-Stage Endometrial Carcinoma Reveals New Dysregulated Pathways Associated with Cell Death and Cell Signaling
Álvaro López‐Janeiro, Ignacio Ruz‐Caracuel, Jorge Luis Ramón-Patiño, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 794-794
Open Access | Times Cited: 37
Upgrading Treatment and Molecular Diagnosis in Endometrial Cancer—Driving New Tools for Endometrial Preservation?
Miriam Dellino, Marco Cerbone, Antonio Simone Laganà, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9780-9780
Open Access | Times Cited: 16
The impact of estrogen receptor and L1 cell adhesion molecule expression on endometrial cancer outcome correlates with clinicopathological risk group and molecular subgroup
Karoliina Aro, Annukka Pasanen, Ralf Bützow, et al.
Gynecologic Oncology (2024) Vol. 189, pp. 9-15
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top